Volume 195, Issue 8 e4702
Original research

Seropositivity to louping ill virus in dogs in the UK

Iris Elgueta

Iris Elgueta

Internal Medicine Service, Vets Now Referral Hospital, Glasgow, UK

Search for more papers by this author
Kayleigh Allen

Kayleigh Allen

Virus Surveillance Unit, Moredun Research Institute, Penicuik, UK

Search for more papers by this author
Theofanis Liatis

Theofanis Liatis

Neurology & Neurosurgery Service, Queen Mother Hospital for Animals, Royal Veterinary College, Hatfield, UK

Search for more papers by this author
Verónica Gonzalo-Nadal

Verónica Gonzalo-Nadal

Southfields Veterinary Specialist, Basildon, UK

Search for more papers by this author
Eleanor Laming

Eleanor Laming

Virus Surveillance Unit, Moredun Research Institute, Penicuik, UK

Search for more papers by this author
Mark P. Dagleish

Mark P. Dagleish

Division of Veterinary Pathology, Public Health and Disease Investigation, School of Biodiversity, One Health and Veterinary Medicine, University of Glasgow, Glasgow, UK

Search for more papers by this author
Pauline M. Jamieson

Pauline M. Jamieson

Internal Medicine Service, Vets Now Referral Hospital, Glasgow, UK

Search for more papers by this author
Giles Innocent

Giles Innocent

Biomathematics and Statistics Scotland, Edinburgh, UK

Search for more papers by this author
Mara S. Rocchi

Corresponding Author

Mara S. Rocchi

Virus Surveillance Unit, Moredun Research Institute, Penicuik, UK

Correspondence

Mara Rocchi, Virus Surveillance Unit, Moredun Research Institute, Penicuik, UK.

Email: [email protected]

Search for more papers by this author
First published: 30 September 2024

Abstract

Background

Louping ill virus (LIV) is a tick-borne flavivirus that can cause fatal meningoencephalomyelitis in dogs. Four dogs with confirmed LIV infection and a case series of dogs with suspected flavivirus infection have been reported in the UK. However, underreporting of LIV infection due to lack of testing is suspected.

Methods

Surplus serum/plasma from 220 dogs was used to determine the seroprevalence of LIV by haemagglutination inhibition (HAI) test. Signalment and environmental factors were investigated for potential correlations with a positive titre (serum dilution of 1:20 or more).

Results

Two hundred and two dogs were suitable for inclusion in the study, nine of which (4.5%) were seropositive. Among the dogs investigated for neurological disease (40/202; 19.8%), six (15%) were seropositive. Ectoparasiticide use approached significance (p = 0.055) for being protective against LIV seropositivity.

Limitations

The main limitations were the specificity of the HAI test, the relatively small number of samples, the low number of seropositive dogs, the poor geographical distribution of the samples and the inherent limitations of questionnaire-based research.

Conclusion

The seroprevalence of LIV in the UK dog population appears to be low. However, LIV should be considered in dogs presenting with unexplained acute or subacute progressive neurological clinical signs, especially because of the recent reports of several dogs with clinical flavivirus infections.

CONFLICT OF INTEREST STATEMENT

The authors declare no conflicts of interest.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available upon request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.